Stranger Things 5: The Finale took us down many winding roads. And, it kind of felt like it had five separate endings, given all the different pieces of its epilogue ...
Not content to just put out one twisty movie at the holiday season with Wake Up Dead Man, Netflix decided to open the floodgates – pun fully intended – with South Korean disaster movie The Great Flood ...
When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...
The first season of HBO's It: Welcome to Derry has come to a close, leaving us with a long list of questions that need to somehow be answered when the show leaps back in time another 27 years for ...
Netflix's new show The Abandons has a true cliffhanger ending, and we're here to break it down. One of the love stories of the season does get a (kind of) resolution. Did [SPOILER] and [SPOILER] ...
Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...
After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...
Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...
Discover What’s Streaming On: There’s a 2023 thriller movie, Some Other Woman, that recently began streaming on Netflix and has subscribers extremely confused. If that’s you, then you’ve come to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results